Clinical Trial Update: Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy and safety of neoadjuvant intravesical Mitomycin C in high-risk non-muscle-invasive bladder cancer. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Shaogang Wang | Conditions: Non-Muscle-Invasive Bladder Cancer (NMIBC) | Phase 3 | Status: RECRUITING